[HTML][HTML] Anticancer potential of alkaloids: a key emphasis to colchicine, vinblastine, vincristine, vindesine, vinorelbine and vincamine

P Dhyani, C Quispe, E Sharma, A Bahukhandi… - Cancer cell …, 2022 - Springer
Cancer, one of the leading illnesses, accounts for about 10 million deaths worldwide. The
treatment of cancer includes surgery, chemotherapy, radiation therapy, and drug therapy …

[HTML][HTML] HIV Infection: Shaping the Complex, Dynamic, and Interconnected Network of the Cytoskeleton

R Cabrera-Rodríguez, S Pérez-Yanes… - International journal of …, 2023 - mdpi.com
HIV-1 has evolved a plethora of strategies to overcome the cytoskeletal barrier (ie, actin and
intermediate filaments (AFs and IFs) and microtubules (MTs)) to achieve the viral cycle. HIV …

Discovery of novel benzimidazole and indazole analogues as tubulin polymerization inhibitors with potent anticancer activities

Y Ren, Y Wang, G Li, Z Zhang, L Ma… - Journal of Medicinal …, 2021 - ACS Publications
Novel indazole and benzimidazole analogues were designed and synthesized as tubulin
inhibitors with potent antiproliferative activities. Among them, compound 12b exhibited the …

Novel indole-pyrazole hybrids as potential tubulin-targeting agents; Synthesis, antiproliferative evaluation, and molecular modeling studies

M Hawash, SG Ergun, DC Kahraman, A Olgac… - Journal of Molecular …, 2023 - Elsevier
Abstract Structurally diverse indole-3-pyrazole-5-carboxamide analogues (10-29) were
designed, synthesized, and evaluated for their antiproliferative activity against three cancer …

SB226, an inhibitor of tubulin polymerization, inhibits paclitaxel-resistant melanoma growth and spontaneous metastasis

S Deng, S Banerjee, H Chen, S Pochampally, Y Wang… - Cancer letters, 2023 - Elsevier
Extensive preclinical studies have shown that colchicine-binding site inhibitors (CBSIs) are
promising drug candidates for cancer therapy. Although numerous CBSIs were generated …

Design, synthesis and biological evaluation of novel acridine and quinoline derivatives as tubulin polymerization inhibitors with anticancer activities

Y Ren, Y Ruan, B Cheng, L Li, J Liu, Y Fang… - Bioorganic & Medicinal …, 2021 - Elsevier
A series of acridine and quinoline derivatives were designed and synthesized based on our
previous work as novel tubulin inhibitors targeting the colchicine binding site. Among them …

[HTML][HTML] Design, synthesis and antiproliferative screening of newly synthesized acrylate derivatives as potential anticancer agents

DS Alshaya, RMO Tawakul, I Zaki, AHA Almaaty… - RSC …, 2023 - pubs.rsc.org
A new series of acrylic acid and acrylate ester derivatives as modified analogs of tubulin
polymerization inhibitors were designed and synthesized. The antiproliferative activity of the …

Microtubule‐targeting agents for cancer treatment: Seven binding sites and three strategies

X Wang, B Gigant, X Zheng, Q Chen - MedComm–Oncology, 2023 - Wiley Online Library
Microtubules are pivotal in diverse cellular functions encompassing cell signaling,
morphology, intracellular trafficking, and cell mitosis/division. They are validated targets for …

Design, synthesis, and biological evaluation of novel diphenylamine derivatives as tubulin polymerization inhibitors targeting the colchicine binding site

XY Yan, JF Leng, TT Chen, YJ Zhao, LY Kong… - European Journal of …, 2022 - Elsevier
A novel series of diphenylamine derivatives were designed and synthesized, and their
biological activities were evaluated. The anti-proliferative activities of the derivatives were …

Discovery and biological evaluation of 4, 6-pyrimidine analogues with potential anticancer agents as novel colchicine binding site inhibitors

J Zhang, L Tan, C Wu, Y Li, H Chen, Y Liu… - European Journal of …, 2023 - Elsevier
Abstract Novel 4, 6-pyrimidine analogues were designed and synthesized as colchicine
binding site inhibitors (CBSIs) with potent antiproliferative activities. Among them, compound …